Method for the determination of soluble gpc3 protein
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- CHUGAI PHARMA CO LTD
- Publication Date
- 2019-08-16
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a method for measuring soluble GPC3 protein in a test sample, characterized by using two different antibodies that bind to different epitopes present in the N-terminal region of the GPC3 protein. Background technique
[0002] It is reported that there are about 600,000 deaths per year caused by hepatocellular carcinoma, ranking fifth among the deaths caused by cancer in the world (Non-Patent Document 1). Most patients with HCC die within 1 year of diagnosis of the disease. Unfortunately, there are frequent instances of HCC being diagnosed at a later stage when curative therapies are less effective. Medical treatments, including chemotherapy, chemoembolization, cautery, and proton beam therapy, remain insufficiently effective in these patients. Most of the patients showed disease recurrence, which was accompanied by vascular invasion and multi-site intrahepatic metastases rapidly developed to the advanced stage, and th...